Overview
Financials
The financial statement for 2022 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2021.
Results vs industry
Industry
Bank accounts
Was a VAT taxpayer from 2006-07-12 to 2025-11-13. Removed from VAT register
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
10 closed proceedings recorded in KRZ history. Closed proceedings in history
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Jul 8, 2026 | Discontinued enforcement proceedings | Closed | |
| Jun 17, 2026 | Discontinued enforcement proceedings | Closed | |
| Jun 12, 2026 | Discontinued enforcement proceedings | Closed | |
| Dec 6, 2025 | Discontinued enforcement proceedings | Closed | |
| Nov 28, 2025 | Discontinued enforcement proceedings | Closed |
Public aid
5 public aid cases recorded, with a total value of $887,204.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 22, 2018 | Aid for research and development projects: industrial research | $227.5K$227,487 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jun 22, 2018 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $138.5K$138,547 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jun 22, 2018 | Aid for research and development projects: experimental development | $84,892$84,892 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
The following is authorized to submit declarations of will on behalf of the company: A. the President of the Management Board – individually; B. the other members of the management board – acting jointly with the President of the Management Board or a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 814 | $164,910.86 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Jacek Marek Wojciechowicz (49)  | Akcjonariusz i prezes zarzadu inno-gene s.a. |
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Medgeneticssp. z o.o. | 2,701.24 USD | 100% | ||
Genetyka Plussp. z o.o. | 324.15 USD | 24% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MedappS.A. | $3,351,163.61 | medapp.pl | ||
| BiotechnaS.A. | $2,472,888.07 | bsbiotechna.com | ||
| GenxoneS.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Dystrogen TherapeuticsS.A. | — | dystrogen.com | ||
| MIMO BiotechP.S.A. | — | mimobiotech.com |
Change history
| Date | Event | |
|---|---|---|
| 2020-09-21 | Address change (Poznań → Ul. Piotra Ściegiennego 20, 60-128, Poznań) | |
| 2019-07-08 | Address change (Ul. Inflancka 25, 61-132, Poznań → Poznań) | |
| 2018-05-25 | Address change (Rubież 46, 61-612, Poznań → Ul. Inflancka 25, 61-132, Poznań) | |
| 2016-05-09 | PKD change (Removed: 32.99.Z, 46.18.Z, 46.19.Z, 46.46.Z, 47.19.Z, 47.73.Z, 47.74.Z, 58.11.Z, 58.12.Z, 58.13.Z, 58.14.Z, 58.19.Z, 58.21.Z, 58.29.Z, 59.20.Z, 60.10.Z, 60.20.Z, 62.01.Z, 62.03.Z, 62.09.Z, 63.11.Z, 63.12.Z, 63.99.Z, 68.10.Z, 68.20.Z, 71.20.B, 74.10.Z, 77.40.Z, 82.30.Z, 82.99.Z, 86.21.Z, 86.22.Z, 96.09.Z) | |
| 2012-02-29 | Share capital change (150,000.00 PLN → 610,500.00 PLN) |
FAQ
Last updated: 2026-04-13